Fig. 6From: Identification of tumor antigens and anoikis-based molecular subtypes in the hepatocellular carcinoma immune microenvironment: implications for mRNA vaccine development and precision treatmentA Delta area curve. B Pyroptosis-associated lncRNAs identified using tenfold cross-validated lasso analysis. C Survival analysis of high and low risk groups of ARI score for progression-free survival. D The performance of anoikis-related lncRNA signatures in the combined group, including the OS survival curve, the risk map of survival time, the risk heat map of 7-lncRNAs, and the AUC curve of the model. E The performance of anoikis-related lncRNA signatures in the test group, including the OS survival curve, the risk map of survival time, the risk heat map of 7-lncRNAs, and the AUC curve of the model. F The performance of anoikis-related lncRNA signatures in the test group, including the OS survival curve, the risk map of survival time, the risk heat map of 7-lncRNAs, and the AUC curve of the model. G Dual-scoring nomogram with ARI and ARG score in TCGA cohort. (H) ROC curve of integrated nomogram. I AUC analysis of integrated nomogramBack to article page